Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  13 results for ""Liver-Specific Organic Anion Transporter 1""

Your Filters

Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Regulatory guidelines do not accurately predict tolvaptan and metabolite interactions at BCRP, OATP1B1, and OAT3 transporters.

  • Authors : Shoaf SE; Quantitative Pharmacology, Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland, USA.; Bricmont P

Subjects: ATP Binding Cassette Transporter, Subfamily G, Member 2/ATP Binding Cassette Transporter, Subfamily G, Member 2/ATP Binding Cassette Transporter, Subfamily G, Member 2/*antagonists & inhibitors ; Drug Approval/Drug Approval/Drug Approval/*statistics & numerical data ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*antagonists & inhibitors

  • Source: Clinical and translational science [Clin Transl Sci] 2021 Jul; Vol. 14 (4), pp. 1535-1542. Date of Electronic Publication: 2021 Apr 09.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Variability in In Vitro OATP1B1/1B3 Inhibition Data: Impact of Incubation Conditions on Variability and Subsequent Drug Interaction Predictions.

  • Authors : McFeely SJ; Department of Pharmaceutics, UW Drug Interaction Solutions, University of Washington, Seattle, Washington, USA.; Ritchie TK

Subjects: Drug Evaluation, Preclinical/Drug Evaluation, Preclinical/Drug Evaluation, Preclinical/*methods ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*antagonists & inhibitors ; Solute Carrier Organic Anion Transporter Family Member 1B3/Solute Carrier Organic Anion Transporter Family Member 1B3/Solute Carrier Organic Anion Transporter Family Member 1B3/*antagonists & inhibitors

  • Source: Clinical and translational science [Clin Transl Sci] 2020 Jan; Vol. 13 (1), pp. 47-52. Date of Electronic Publication: 2019 Sep 28.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017.

  • Authors : Yu J; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington .; Petrie ID

Subjects: Area Under Curve* ; Drug Interactions*; Cytochrome P-450 CYP3A Inhibitors/Cytochrome P-450 CYP3A Inhibitors/Cytochrome P-450 CYP3A Inhibitors/*pharmacology

  • Source: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2019 Feb; Vol. 47 (2), pp. 135-144. Date of Electronic Publication: 2018 Nov 15.Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550

Record details

Read More Add to Saved list
×
Academic Journal

Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial.

  • Authors : Vassy JL; VA Boston Healthcare System, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Subjects: Cholesterol, LDL/Cholesterol, LDL/Cholesterol, LDL/*drug effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*drug effects

  • Source: JAMA network open [JAMA Netw Open] 2020 Dec 01; Vol. 3 (12), pp. e2027092. Date of Electronic Publication: 2020 Dec 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Inhibitors of Organic Anion-Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective.

  • Authors : McFeely SJ; University of Washington Drug Interaction Solutions, Seattle, Washington, USA.; Ritchie TK

Subjects: Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*antagonists & inhibitors ; Solute Carrier Organic Anion Transporter Family Member 1B3/Solute Carrier Organic Anion Transporter Family Member 1B3/Solute Carrier Organic Anion Transporter Family Member 1B3/*antagonists & inhibitors; Animals

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2020 Aug; Vol. 60 (8), pp. 1087-1098. Date of Electronic Publication: 2020 Mar 20.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

Read More Add to Saved list
×
Academic Journal

Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.

  • Authors : Weiner M; University of Texas Health Science Center, San Antonio, San Antonio, Texas, USA .; South Texas Veterans Health Care System, San Antonio, Texas, USA.

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*blood ; Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*therapeutic use ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*genetics

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2018 Apr 26; Vol. 62 (5). Date of Electronic Publication: 2018 Apr 26 (Print Publication: 2018).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.

  • Authors : Dong OM; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Center for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Subjects: Drug Costs* ; Pharmacogenomic Variants*; Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*economics

  • Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jan; Vol. 23 (1), pp. 61-73. Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.

  • Authors : Chanfreau-Coffinier C; US Department of Veterans Affairs, VA Informatics and Computing Infrastructure, Salt Lake City Health Care System, Salt Lake City, Utah.; Hull LE

Subjects: Veterans Health*; Gene Frequency/Gene Frequency/Gene Frequency/*genetics ; Pharmacogenomic Variants/Pharmacogenomic Variants/Pharmacogenomic Variants/*genetics

  • Source: JAMA network open [JAMA Netw Open] 2019 Jun 05; Vol. 2 (6), pp. e195345. Date of Electronic Publication: 2019 Jun 05.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes among five ethnic groups.

  • Authors : Namgoong S; Department of Life Science, Sogang University, Seoul, Republic of Korea; Research Institute for Basic Science, Sogang University, Seoul, Republic of Korea.

Subjects: Polymorphism, Single Nucleotide*; Ethnicity/Ethnicity/Ethnicity/*genetics ; Organic Anion Transporters/Organic Anion Transporters/Organic Anion Transporters/*genetics

  • Source: Environmental toxicology and pharmacology [Environ Toxicol Pharmacol] 2015 Nov; Vol. 40 (3), pp. 692-7. Date of Electronic Publication: 2015 Sep 03.Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9612020 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.

Subjects: Asian People/Asian People/Asian People/*genetics ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacokinetics ; Rosuvastatin Calcium/Rosuvastatin Calcium/Rosuvastatin Calcium/*pharmacokinetics

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2015 Mar; Vol. 71 (3), pp. 329-40. Date of Electronic Publication: 2015 Jan 30.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

Read More Add to Saved list
×
  • 1-10 of  13 results for ""Liver-Specific Organic Anion Transporter 1""